Toripalimab(240Mg/6Ml) shortage status
1 active shortage notice across 1 country.
Last updated 22 May 2026 · sourced from official medicines regulators
- Generic name (INN)
- Toripalimab(240Mg/6Ml)
- Brand names
- Loqtorzi Concentrate For Solution For Infusion
- Class
- Auto-created by Health Sciences Authority — Singapore Post-Registration Actions scraper
Where Toripalimab(240Mg/6Ml) is in shortage
Why Toripalimab(240Mg/6Ml) is in shortage
- supply-chain disruption — e.g. “Marketing authorisation holder transfer” (Singapore)
Frequently asked questions
Is Toripalimab(240Mg/6Ml) currently in shortage?
Yes. As of the latest regulator updates, Toripalimab(240Mg/6Ml) has 1 active shortage notice across 1 country (Singapore). Status is refreshed daily from official regulatory sources.
Why is Toripalimab(240Mg/6Ml) in shortage?
Regulators attribute the current Toripalimab(240Mg/6Ml) shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Toripalimab(240Mg/6Ml) shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Toripalimab(240Mg/6Ml) status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.